Condition

ARB clinical trials and research

• 2Clinical trials
• 2Countries

All recruiting trials (2)

• OPGx-BEST1 subretinal gene therapy for Best vitelliform macular dystrophy and autosomal-recessive bestrophinopathy

  This trial will test whether a one-time subretinal gene therapy called OPGx-BEST1 is safe and can improve or stabilize vision in adults with Best vitelliform macular dystrophy (BVMD) or autosomal-recessive bestrophinopathy (ARB) in one eye.

  Recruiting at 4 sites Phase 1/2 Opus Genetics, Inc · Los Angeles, California and 4 other locations · NCT07185256

• Evaluating the impact of influenza vaccination and certain medications on COVID-19 outcomes

  This study is trying to see if getting the flu vaccine or taking certain medications helps people in the hospital recover better from COVID-19.

  Recruiting Consorci Sanitari de Terrassa · Terrassa, Barcelona · NCT04367883

Related topics

Quick answers

How many ARB clinical trials are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 2 countries. The most sites are in Spain (1 trial), United States (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →